These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 1320232

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Law CB, Ting SM, Li P, Lai KN.
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A, Paoletti E, Molinelli G.
    Adv Perit Dial; 1990 Nov; 6():292-5. PubMed ID: 1982830
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK, Yilmaz ME, Sit D, Kara IH, Isikoglu B.
    Ren Fail; 2005 Nov; 27(4):367-72. PubMed ID: 16060121
    [Abstract] [Full Text] [Related]

  • 6. rHuEPO in the treatment of postpartum anemia: subcutaneous versus intravenous administration.
    Zimmermann R, Breymann C, Huch R, Huch A.
    Clin Investig; 1994 Nov; 72(6 Suppl):S25-30. PubMed ID: 7950168
    [Abstract] [Full Text] [Related]

  • 7. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC, Lee EJ.
    Adv Perit Dial; 1991 Nov; 7():285-7. PubMed ID: 1680447
    [Abstract] [Full Text] [Related]

  • 8. Treatment of the anemia with human recombinant erythropoietin in CAPD patients.
    Miranda B, Selgas R, Riñon C, Fernandez-Zamorano A, Borrego F, Ortuño F, Lopez-Revuelta K, Torre A, Sanchez Sicilia L.
    Adv Perit Dial; 1990 Nov; 6():296-301. PubMed ID: 1982831
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and pharmacodynamic studies on recombinant human erythropoietin.
    Salmonson T.
    Scand J Urol Nephrol Suppl; 1990 Nov; 129():1-66. PubMed ID: 2255869
    [Abstract] [Full Text] [Related]

  • 10. Haemoglobin response to subcutaneous versus intravenous epoetin alfa administration in iron-replete haemodialysis patients.
    Leikis MJ, Kent AB, Becker GJ, McMahon LP.
    Nephrology (Carlton); 2004 Jun; 9(3):153-60. PubMed ID: 15189176
    [Abstract] [Full Text] [Related]

  • 11. Erythropoietin for anaemia in haemodialysis patients: results of a maintenance study (the Canadian Erythropoietin Study Group).
    Muirhead N, Laupacis A, Wong C.
    Nephrol Dial Transplant; 1992 Jun; 7(8):811-6. PubMed ID: 1325613
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Subcutaneous recombinant human erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Pais MJ, Gaspar A, Santana A, Bruges M, Simões J.
    Perit Dial Int; 1993 Jun; 13 Suppl 2():S541-3. PubMed ID: 8399660
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K, Stompór T, Gryz E, Szczudlik A, Drozdz M, Kraśniak A, Sułowicz W.
    Przegl Lek; 2007 Jun; 64(6):423-30. PubMed ID: 18159852
    [Abstract] [Full Text] [Related]

  • 17. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y, Ito K.
    Adv Perit Dial; 1992 Jun; 8():448-52. PubMed ID: 1361845
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of intravenous and subcutaneous erythropoietin in patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Lai PC, Wu MS, Huang JY, Huang CC, Leu ML.
    Changgeng Yi Xue Za Zhi; 1994 Jun; 17(2):105-12. PubMed ID: 8069732
    [Abstract] [Full Text] [Related]

  • 19. Efficacy prospective study of different frequencies of Epo administration by i.v. and s.c. routes in renal replacement therapy patients.
    Messa P, Nicolini MA, Cesana B, Brezzi B, Zattera T, Magnasco A, Moroni G, Campise M.
    Nephrol Dial Transplant; 2006 Feb; 21(2):431-6. PubMed ID: 16249199
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.